BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4361973)

  • 1. Effect of various ACTH preparations and of metyrapone on the secretion of growth hormone in normal subjects and in hypopituitary patients.
    Lee PA; Keenan BS; Migeon CJ; Blizzard RM
    J Clin Endocrinol Metab; 1973 Sep; 37(3):389-96. PubMed ID: 4361973
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimation of ACTH reserve on normal and hypopituitary subjects: comparison of oral and intravenous metyrapone with insulin hypoglycemia.
    Keenan BS; Beitins IZ; Lee PA; Kowarski A; Blizzard RM; Migeon CJ
    J Clin Endocrinol Metab; 1973 Oct; 37(4):540-9. PubMed ID: 4355091
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous metyrapone testing. Evaluation of growth hormone and adrenocorticotrophic hormone in children.
    Bacon GE; Larson RM; Spencer ML; Kelch RP
    Am J Dis Child; 1975 Sep; 129(9):1042-4. PubMed ID: 1190177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulus specificity of defects in counterregulatory hormone secretion in insulin-dependent diabetes mellitus: effect of glycemic control.
    Kinsley BT; Widom B; Utzschneider K; Simonson DC
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1383-9. PubMed ID: 7962332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stimulation of growth hormones in children with ACTH].
    Girard J; Stahl M; Bühler U
    Schweiz Med Wochenschr; 1971 Jun; 101(25):930-2. PubMed ID: 4326529
    [No Abstract]   [Full Text] [Related]  

  • 7. [Secretion of corticotropin and somatotropin during the insulin test in partial hypopituitarism].
    Materazzi F; Rolla M; Menchini GF; Pennisi F
    Folia Endocrinol; 1971; 24(3):331-9. PubMed ID: 4332743
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of adrenocorticotropin and adrenal steroid responses to corticotropin-releasing hormone versus metyrapone testing in patients with hypopituitarism.
    Riddick L; Chrousos GP; Jeffries S; Pang S
    Pediatr Res; 1994 Aug; 36(2):215-20. PubMed ID: 7970937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of ACTH, insulin hypoglycemia, dexamethasone and metyrapone on corticosterone secretion in healthy subjects: a comparison with cortisol secretion (author's transl)].
    Matsumura S
    Nihon Naibunpi Gakkai Zasshi; 1980 Feb; 56(2):129-38. PubMed ID: 6245941
    [No Abstract]   [Full Text] [Related]  

  • 10. Counter-regulatory hormone responses to insulin-induced acute hypoglycemia in hypopituitary patients.
    Garg A; Grizzle WE; Kansal PC; Stabler TV; Boots LR
    Horm Metab Res; 1994 Jun; 26(6):276-82. PubMed ID: 7927190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent steroid therapy. Its effect on hypothalamic-pituitary-adrenal function and the response of plasma growth hormone and insulin to stimulation.
    Martin MM; Gaboardi F; Podolsky S; Raiti S; Calcagno PL
    N Engl J Med; 1968 Aug; 279(6):273-8. PubMed ID: 4298259
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of metyrapone on secretion of growth hormone in man.
    Kunita H; Takebe K; Nakagawa K; Sawano S; Horiuchi Y
    J Clin Endocrinol Metab; 1970 Sep; 31(3):301-6. PubMed ID: 4318201
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of metopirone on growth hormone, glycemia, and plasma insulin].
    Szöts F; Nadeau A; Tremblay R
    Union Med Can; 1973 Mar; 102(3):591-5. PubMed ID: 4351570
    [No Abstract]   [Full Text] [Related]  

  • 14. A challenge to the concept that ACTH affects growth hormone secretion in man.
    Byyny RL; Orth DN; Nicholson WE; Liddle GW
    J Clin Endocrinol Metab; 1972 Jun; 34(6):1093-6. PubMed ID: 4336458
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenal androgen response to metyrapone, adrenocorticotropin, and corticotropin-releasing hormone stimulation in children with hypopituitarism.
    Pang SY; Legido A; Levine LS; Temeck JW; New MI
    J Clin Endocrinol Metab; 1987 Aug; 65(2):282-9. PubMed ID: 3036902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The advantages of combined stimulation by arginine and insulin in the study of the secretion of growth hormone.
    Ruitton A; Tell G; David M; Rocard E
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):846-54. PubMed ID: 4653986
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormalities in growth hormone and insulin release in short but otherwise normal patients. The arginine-insulin-glucose (AIGT) stimulation and suppression test.
    Raiti S; Maclaren N; Trias E; Kim C
    Horm Res; 1977; 8(2):93-8. PubMed ID: 908554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determinations of plasma ACTH and GH levels after an oral metyrapone.
    Sawano S; Saito T; Shizume K; Takebe K
    Endocrinol Jpn; 1972 Oct; 19(5):477-81. PubMed ID: 4346864
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of alpha-MSH on plasma growth hormone, cortisol and TSH in children.
    Bernasconi S; Torresani T; Illig R
    J Clin Endocrinol Metab; 1975 May; 40(5):759-63. PubMed ID: 165218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of the adrenergic nervous system and growth hormone release in normal adults and children with various growth disorders.
    Lee PA; Thompson RG; Blizzard RM
    Metabolism; 1974 Jul; 23(7):595-601. PubMed ID: 4365599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.